A vaccine platform against arenaviruses based on a recombinant hyper-attenuated Mopeia virus expressing heterologous glycoproteins. (Q52625005)
Jump to navigation
Jump to search
scientific article published on 28 March 2018
Language | Label | Description | Also known as |
---|---|---|---|
English | A vaccine platform against arenaviruses based on a recombinant hyper-attenuated Mopeia virus expressing heterologous glycoproteins. |
scientific article published on 28 March 2018 |
Statements
A vaccine platform against arenaviruses based on a recombinant hyper-attenuated Mopeia virus expressing heterologous glycoproteins. (English)
Audrey Page
Jimmy Hortion
Caroline Picard
Elsie Yekwa
28 March 2018